COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1097: Articles 10961-10970  | Next

Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2.
Barreiro, A., Prenafeta, A., Bech-Sabat, G., Roca, M., March, R., Gonzalez, L., Madrenas, L., Corominas, J., Fernandez, A., Molas, M., Vergara-Alert, J., Lorca-Oro, C., Roca, N., Fernandez-Bastit, L., Rodon, J., Perez, M., Segales, J., Pradenas, E., Marfil, S., Trinite, B., Ortiz, R., Clotet, B., Blanco, J., Diaz Pedroza, J., Ampudia Carrasco, R., Rosales Salgado, Y., Loubat Casanovas, J., Capdevila Larripa, S., Garcia Prado, J., Barretina Ginesta, J., Sistere-Oro, M., Cebollada Rica, P., Meyerhans, A., Ferrer, L., Torroella, E.
10.1101/2021.11.22.469117 — Posted: 2021-11-23
A multi-class gene classifier for SARS-CoV-2 variants based on convolutional neural network
Fan, J., Chen, C., Song, C., Pan, J., Wu, G.
10.1101/2021.11.22.469492 — Posted: 2021-11-23
Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
Vanderwall, E. R., Barrow, K. A., Rich, L. M., Read, D. F., Trapnell, C., Oghenemega, O., Ziegler, S. F., Hallstrand, T. S., White, M. P., Debley, J. S.
10.1101/2021.11.20.469409 — Posted: 2021-11-23
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in patients with rheumatic diseases
Arumahandi de Silva, A. N., Frommert, L. M., Albach, F. N., Klotsche, J., Scholz, V., ten Hagen, A., Jeworowski, L. M., Schwarz, T., Zernicke, J., Corman, V. M., Drosten, C., Burmester, G. R., Biesen, R.
10.1101/2021.11.17.21266441 — Posted: 2021-11-23
Space-time Classification Index for Assessing COVID-19 Hotspots
Haynes, D., Tiwari, C.
10.1101/2021.11.17.21266461 — Posted: 2021-11-23
Decidual immune response following COVID-19 during pregnancy varies by timing of maternal SARS-CoV-2 infection
Juttukonda, L. J., Wachman, E. M., Boateng, J., Jain, M., Benarroch, Y., Taglauer, E. S.
10.1101/2021.11.20.469369 — Posted: 2021-11-22
Hypertonic saline and aprotinin based blockage of SARS-CoV-2 specific furin site cleavage by inhibition of nasal protease activity
Li, A., Li, C. T.
10.1101/2021.11.19.469276 — Posted: 2021-11-22
Acute SARS-CoV-2 infection in pregnancy is associated with placental ACE-2 shedding
Taglauer, E. S., Wachman, E. M., Juttukonda, L., Klouda, T., Kim, J., Wang, Q., Ishiyama, A., Hackam, D. J., Yuan, K., Jia, H.
10.1101/2021.11.19.469335 — Posted: 2021-11-22
Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2
Mallick Gupta, A., Mandal, S. C., Chakrabarti, J., Mandal, S.
10.1101/2021.11.18.469065 — Posted: 2021-11-22
Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery
Rosati, E., Pogorelyy, M. V., Minervina, A. A., Franke, A., Scheffold, A., Bacher, P., Thomas, P.
10.1101/2021.11.19.469229 — Posted: 2021-11-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).